Clinical Trial

DETECT: Target Volume for Rectal Endoluminal Radiation Boosting

Study acronym: DETECT
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-06-09; most recent amendment 2025-07-24.
Status change: Not Yet Recruiting → Recruiting 2022-08-24
Trial Details
NCT Number NCT04927897
Lead Sponsor Maastricht Radiation Oncology
Collaborators: Maastricht University Medical Center, Catharina Ziekenhuis Eindhoven
Conditions Rectal Cancer
Enrollment 50 participants
Start Date 2022-08-16
Primary Completion 2027-05 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-28